Acquired Resistance to Small Molecule ErbB2 Tyrosine Kinase Inhibitors

Franklin L. Chen; Wenle Xia; Neil L. Spector

doi:10.1158/1078-0432.CCR-08-0581

AACR Publications

AACR logo

Register
Log in
My Cart

Main menu

Home
About
Articles
For Authors
Alerts
News
- Cancer Discovery News
COVID-19
Webinars
Search More

Search for this keyword

Advanced Search

AACR Publications

User menu

Register
Log in
My Cart

Search

Search for this keyword

Advanced search

Home
About
Articles
For Authors
Alerts
News
- Cancer Discovery News
COVID-19
Webinars
Search More

Search for this keyword

Advanced Search

Molecular Pathways

Acquired Resistance to Small Molecule ErbB2 Tyrosine Kinase Inhibitors

Franklin L. Chen, Wenle Xia and Neil L. Spector

Franklin L. Chen

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Wenle Xia

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Neil L. Spector

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

DOI: 10.1158/1078-0432.CCR-08-0581 Published November 2008

Article
Figures & Data
Info & Metrics
PDF

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: November 2008 to January 2021

	Abstract	Full-text HTML	PDF
Total	3440	6260	4520

Cited By

Article Information

Volume 14, Issue 21, pp. 6730-6734

DOI

https://doi.org/10.1158/1078-0432.CCR-08-0581

PubMed

18980964

Published By

American Association for Cancer Research

Print ISSN

1078-0432

Online ISSN

1557-3265

History

Accepted August 14, 2008
Received August 13, 2008
Revision received August 14, 2008
Published first November 3, 2008.

American Association for Cancer Research

Author Information

Franklin L. Chen1,
Wenle Xia2 and
Neil L. Spector1,2

Authors' Affiliations:¹Duke University Medical Center, Department of Medicine, Division of Medical Oncology, and ²Duke Comprehensive Cancer Center, Durham, North Carolina

Requests for reprints:
Neil L. Spector, Duke University, 2424 Erwin Road, Hock Plaza, Suite 601, Durham, NC 27710. Phone: 919-681-4699; Fax: 919-684-5653; E-mail: Neil.Spector{at}duke.edu.

View Full Text

PreviousNext

November 2008
Volume 14, Issue 21

Table of Contents
Table of Contents (PDF)
About the Cover

Search for this keyword

View this article with LENS

Open full page PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Clinical Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Acquired Resistance to Small Molecule ErbB2 Tyrosine Kinase Inhibitors

Message Subject (Your Name) has forwarded a page to you from Clinical Cancer Research

Message Body (Your Name) thought you would be interested in this article in Clinical Cancer Research.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

Acquired Resistance to Small Molecule ErbB2 Tyrosine Kinase Inhibitors